As of 4:00pm ET
| -0.23 / -3.51%|
The 6 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 6.50. The median estimate represents a +73.78% increase from the last price of 6.33.
The current consensus among 6 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.